SAN FRANCISCO--(BUSINESS WIRE)--Savonix, a global leader in digital tests for cognitive health, announced today that the Company will be presenting at the upcoming conferences:
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019
- Poster Presentation: Improving Dementia Economics Through Earlier Cost-Effective Assessment
- Research Poster Presentations – Session 2
- Study authors: Dr. Kevin Carroll, Dr. Jim McCollum, Dr. Mylea Charvat
- Presenter: Dr. Kevin Carroll, US Clinical Director, Savonix
- May 20, 3:30 PM - 7:00 PM, Poster Author Discussion Hour: 6:00 PM - 7:00 PM
- New Orleans Ernest N. Morial Convention Center, New Orleans, LA
Dr. Mylea Charvat, CEO and Founder of Savonix will be speaking at the following conferences:
- Brain Health Panel: Beyond Dementia: The REALLY Big Opportunities in Neuroscience
- Jun 4, 11:00 AM – 12:15 PM ET
- Philadelphia Convention Center, 116, Level 100
Global CEO Initiative on Alzheimer’s Disease (CEOi) and Ministry of Economy, Trade and Industry of Japan (METI) Roundtable Discussion on Brain Health
- Presentation: Scaling Support through Technology
- June 5, 2:00 – 5:00 PM
- AARP Global Headquarters, 601 E Street, NW, Washington, DC
Global Insurtech Leaders Summit
- Panel: What Insurance Innovation for Longevity and Aging Means?
- June 19, 12:35 – 1:15 PM
- One Liberty Plaza, New York, NY
GENTRY Women in Tech Conference 2019
- Panel: Male Allies: The Role of Male Allies in the Success of Women’s Careers: Being and Securing Male Allies as Mentors, Collaborators, & Sponsors
- June 20, 2:00 PM – 6:30 PM
- SAP Palo Alto, 3410 Hillview Avenue, Palo Alto, CA
Geodesic Capital Annual Meeting (closed to press)
- Japan focused Roundtable on Dementia
- July 18, 1:00 PM – 6 PM / July 19, 9:00 AM - 5:00 PM
- San Mateo Marriott, 1770 S Amphlett Blvd, San Mateo, CA
About Savonix
Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet, the Savonix Cognitive Assessment platform is an accurate, accessible and affordable tool for professional cognitive screens. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists and digital health technology experts, the company has established itself as an authority on cognition globally. To learn more about Savonix, visit Savonix.com.
